Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma Price : 1.73 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.81 | 1.84 | 1.72 | 1.73 | 168744.0 |
| Sep 17, 2026 | 1.84 | 1.84 | 1.78 | 1.81 | 33857.00 |
| Sep 16, 2026 | 1.84 | 1.84 | 1.81 | 1.81 | 5529.00 |
| Sep 15, 2026 | 1.79 | 1.89 | 1.76 | 1.85 | 38048.00 |
| Sep 14, 2026 | 1.70 | 1.86 | 1.70 | 1.84 | 53539.00 |
| Sep 11, 2026 | 1.687 | 1.765 | 1.67 | 1.758 | 33200.00 |
| Sep 10, 2026 | 1.69 | 1.73 | 1.621 | 1.68 | 32595.00 |
| Sep 09, 2026 | 1.76 | 1.80 | 1.66 | 1.66 | 81897.00 |
| Sep 08, 2026 | 1.85 | 1.89 | 1.77 | 1.77 | 174359.0 |
| Sep 04, 2026 | 1.67 | 1.91 | 1.66 | 1.84 | 306731.0 |
| Sep 03, 2026 | 1.55 | 1.690 | 1.55 | 1.67 | 47901.00 |
| Sep 02, 2026 | 1.61 | 1.65 | 1.51 | 1.58 | 105403.0 |
| Sep 01, 2026 | 1.72 | 1.850 | 1.52 | 1.65 | 77601.00 |
| Aug 31, 2026 | 1.687 | 1.749 | 1.638 | 1.680 | 53530.00 |
| Aug 28, 2026 | 1.705 | 1.743 | 1.624 | 1.660 | 31981.00 |
| Aug 27, 2026 | 1.883 | 1.883 | 1.574 | 1.687 | 63114.00 |
| Aug 26, 2026 | 1.764 | 1.897 | 1.729 | 1.820 | 96361.00 |
| Aug 25, 2026 | 1.698 | 1.750 | 1.636 | 1.737 | 51063.00 |
| Aug 24, 2026 | 1.804 | 1.804 | 1.540 | 1.624 | 246405.0 |
| Aug 21, 2026 | 2.030 | 2.110 | 2.023 | 2.030 | 42509.00 |
| Aug 20, 2026 | 2.163 | 2.240 | 2.045 | 2.066 | 35510.00 |
| Aug 19, 2026 | 2.173 | 2.205 | 2.107 | 2.167 | 27774.00 |
| Aug 18, 2026 | 2.240 | 2.271 | 2.171 | 2.171 | 31585.00 |
| Aug 17, 2026 | 2.386 | 2.401 | 2.240 | 2.272 | 87141.00 |
| Aug 14, 2026 | 2.444 | 2.474 | 2.332 | 2.387 | 26392.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| Price to Book Value | 1.263 |
| Earnings Yield | -112.6% |
| Market Cap | 5.295M |